top of page

The Future of Precision Neuroscience with Kernel


In the rapidly evolving world of neuroscience, Kernel stands out as a revolutionary force. With its proprietary, first-in-class neurotechnology, Kernel is on a mission to redefine the boundaries of precision neuroscience. The company’s goal? To accelerate treatment discovery, enhance patient outcomes, and transform the realm of neuro medicine.

Kernel’s Pioneering Approach: Neuroscience

Kernel’s unique approach revolves around its state-of-the-art neuroimaging headset, Kernel Flow. This device is designed to collect high-resolution data at the scale required for precision neuroscience. By harnessing the power of advanced AI and ML tools, Kernel is not only developing new biomarkers but also deriving unprecedented, actionable insights from the data.

Key Features of Kernel Flow:
  • Exceptional Ease-of-Use: Kernel Flow is designed to be portable and user-friendly. It can be set up in mere minutes, making research-grade neuroimaging accessible in a variety of real-world settings.

  • Validated and Trusted: The technology is peer-reviewed and backed by over 5000 unique datasets. It builds on decades of scientific advancements and has proven its efficacy in the field.

  • Superior Data Collection: Kernel Flow stands out as the only multimodal neuroimaging headset that combines high-resolution optical hemodynamic imaging (akin to fMRI) with EEG measures. This combination offers advanced, multi-modal data for comprehensive insights.

  • Immediate Insights: Kernel’s advanced data processing pipelines offer seamless access to top-tier data analyses with just a click. These cloud-based analysis tools are scalable, catering to both individual datasets and large-scale population-level analyses.

  • Impacting Treatment Development and Neuromedicine

Kernel’s technology is set to play a pivotal role in various aspects of neuro medicine:

  • Translational Research: Through measurement and analysis, Kernel aids in identifying target engagement.

  • Clinical Trial Optimization: The technology allows for population stratification and quantitative endpoints, enhancing precision in detecting drug effects and determining treatment efficacy.

  • Predicting Treatment Response: Kernel’s technology can help in selecting treatments based on neuro biomarkers.

  • Early Identification: Until now, the accessibility of advanced neuroimaging technologies has been limited. Kernel aims to change this, enabling regular brain measurements and early detection of brain changes for timely interventions.

Participate in a Revolutionary Study on Depression Treatments

Have you been diagnosed with Major Depressive Disorder and are about to begin a new treatment? If so, you might be eligible for an innovative observational study by Kernel. This study aims to understand how the brain reacts to various depression treatments using Kernel Flow, a state-of-the-art, non-invasive brain scanner. This technology uses specific light frequencies to measure brain activity, eliminating the need for magnets or radioactivity.

Eligible patients from selected clinics undergoing treatments like TMS, Ketamine, SPRAVATO, or Antidepressants can participate and will receive a summary of their brain results. 

The study duration can extend up to 3 months, comprising 2-3 primary visits and an option for up to 6 additional short visits. Primary visits, lasting about an hour, involve questionnaire responses and wearing a high-tech headset to record brain activity during specific tasks. Optional visits are shorter, taking up to 20 minutes.

If you’re interested in gaining insights into your brain’s response to depression treatments, come to us for this groundbreaking study! 

Contact Us:

Telephone. 949-776-5103


bottom of page